Loading clinical trials...
Loading clinical trials...
Open-label, Single-arm Study to Assess the Colonization Kinetics of Clinician- Administered Vaginal Live Biotherapeutic Product Containing Multiple Strains of Lactobacillus Crispatus.
Conditions
Interventions
LC106
Locations
2
United States
Massachusetts General Hospital
Boston, Massachusetts, United States
CAPRISA
Vulindlela, South Africa
Start Date
April 22, 2026
Primary Completion Date
May 30, 2026
Completion Date
May 30, 2026
Last Updated
April 15, 2026
NCT07394777
NCT01829204
NCT04046900
NCT04771728
NCT06472765
NCT05666778
Lead Sponsor
Caroline Mitchell
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions